Bessemer Group Inc. Boosts Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Bessemer Group Inc. increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 63.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 296,828 shares of the company's stock after purchasing an additional 114,865 shares during the period. Bessemer Group Inc. owned approximately 0.34% of HealthEquity worth $28,481,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity in the fourth quarter worth approximately $26,000. Smartleaf Asset Management LLC increased its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the period. Proficio Capital Partners LLC bought a new stake in shares of HealthEquity during the fourth quarter worth $39,000. UMB Bank n.a. boosted its stake in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after purchasing an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ grew its holdings in shares of HealthEquity by 1,934.8% in the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after purchasing an additional 445 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now directly owns 84,969 shares of the company's stock, valued at $6,597,842.85. The trade was a 6.34 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,381 shares of company stock worth $1,781,432. 2.20% of the stock is currently owned by company insiders.

Remove Ads

HealthEquity Trading Down 0.3 %

Shares of HealthEquity stock traded down $0.26 during trading hours on Wednesday, hitting $82.77. The company's stock had a trading volume of 157,769 shares, compared to its average volume of 759,444. The firm has a fifty day moving average of $96.47 and a 200-day moving average of $96.35. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market cap of $7.16 billion, a price-to-earnings ratio of 75.94, a P/E/G ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price target for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. The Goldman Sachs Group dropped their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Wells Fargo & Company boosted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Barrington Research restated an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. Finally, KeyCorp cut their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Buy" and a consensus price target of $111.75.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.